MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding MAIA Biotechnology, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 26 | 1 | 33 | +8 |
| Shares | 2.52M | 1.15M | 13.2M | +11.8M (+865.7%) |
| Value | $4.09M | $1.77M | $18.4M | +$16.1M (+691.9%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held MAIA Biotechnology, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Solas Capital Management, LLC | 4,297,004 | $6.02M | 3.46% |
| Alyeska Investment Group, L.P. | 2,500,000 | $3.50M | 0.01% |
| Vanguard Capital Management LLC | 2,074,045 | $2.90M | 0.00% |
| 683 Capital Management, LLC | 1,066,666 | $1.49M | 0.14% |
| Cable Car Capital LLC | 648,503 | $907.9K | 0.31% |
| Bleichroeder LP | 500,000 | $700.0K | 0.12% |
| Vanguard Fiduciary Trust Co | 199,314 | $279.0K | 0.00% |
| Corsair Capital Management, L.P. | 100,000 | $140.0K | 0.02% |
| PVG Asset Management Corp | 34,135 | $46.4K | 0.03% |
| O'Shaughnessy Asset Management, LLC | 20,071 | $28.1K | 0.00% |
| Vanguard Global Advisers, LLC | 11,401 | $16.0K | 0.00% |
| Catalyst Funds Management Pty Ltd | 10,800 | $15.1K | 0.00% |
| FMR LLC | 2 | $2 | 0.00% |
| Royal Bank of Canada | 268 | $0 | 0.00% |
Sold out (6)
Institutions that held MAIA Biotechnology, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Jane Street Group, LLC | 78,757 | $120.5K |
| Susquehanna International Group, LLP | 14,288 | $21.9K |
| StoneX Group Inc. | 10,249 | $15.7K |
| Rocky Mountain Advisers, LLC | 653 | $999 |
| Tucker Asset Management LLC | 341 | $522 |
| Bank of America Corp | 30 | $46 |
Not filed for Q1 2026 yet (1)
Institutions that held MAIA Biotechnology, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 1,154,833 | $1.77M |